Most cancers are characterized by the acquisition of profound mutations in tumor suppressor genes (Rb, PTEN, BRCA1/BRCA2) [24,25,26] or proto-oncogenes (HER2/neu, Ras, Myc, EGFR) [27,28,29,30]. This evidence concerns the gene EGFR and cancer.